# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001513162-20-000167
Filing Date
2020-08-17
Accepted
2020-08-17 08:31:47
Documents
22
Period of Report
2020-08-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | form8k.htm | 8-K | 49335
2 | EXHIBIT 3.1 | exhibit3_1.htm | EX-3.1 | 13906
3 | GRAPHIC | exhibit99_1.htm | EX-99.1 | 3499
4 | GRAPHIC | slide1.jpg | GRAPHIC | 64459
5 | GRAPHIC | slide2.jpg | GRAPHIC | 244269
6 | GRAPHIC | slide3.jpg | GRAPHIC | 134508
7 | GRAPHIC | slide4.jpg | GRAPHIC | 206302
8 | GRAPHIC | slide5.jpg | GRAPHIC | 230043
9 | GRAPHIC | slide6.jpg | GRAPHIC | 204128
10 | GRAPHIC | slide7.jpg | GRAPHIC | 187757
11 | GRAPHIC | slide8.jpg | GRAPHIC | 136883
12 | GRAPHIC | slide9.jpg | GRAPHIC | 218133
13 | GRAPHIC | slide10.jpg | GRAPHIC | 183018
14 | GRAPHIC | slide11.jpg | GRAPHIC | 159919
15 | GRAPHIC | slide12.jpg | GRAPHIC | 159284
16 | GRAPHIC | slide13.jpg | GRAPHIC | 151742
17 | GRAPHIC | slide14.jpg | GRAPHIC | 215563
18 | GRAPHIC | slide15.jpg | GRAPHIC | 192522
19 | GRAPHIC | slide16.jpg | GRAPHIC | 160187
20 | GRAPHIC | slide17.jpg | GRAPHIC | 201693
21 | GRAPHIC | slide18.jpg | GRAPHIC | 145966
22 | GRAPHIC | slide19.jpg | GRAPHIC | 219868
| Complete submission text file | 0001513162-20-000167.txt |  | 4774484

Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 201108014
SIC: 2834 Pharmaceutical Preparations